← Open Payments lookup

ANN MOJEIKO: Open Payments

NPI 1801463245 · CLINTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,233 in 81 payments from 12 companies in 2025. Trend: 2023 $213 · 2024 $567 · 2025 $1,233

Food & beverage: $1,233
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.29$259
Otsuka America Pharmaceutical, Inc.14$234
Teva Pharmaceuticals USA, Inc.9$189
Alkermes, Inc.6$110
ABBVIE INC.5$109
E.R. Squibb & Sons, L.L.C.5$86
Lundbeck LLC4$69
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$58
Axsome Therapeutics, Inc.2$39
Janssen Pharmaceuticals, Inc2$35

Products named: INGREZZA, REXULTI, ARISTADA, VRAYLAR, ABILIFY ASIMTUFII, AUSTEDO XR, UZEDY, COBENFY.

Industry payments across IA — which companies pay providers there.